Pharmacologic prophylaxis alone is not adequate to prevent post-ERCP pancreatitis

American Journal of Gastroenterology

Volumn 109, Issue 6, 2014, Pages 910-912

  Arain, Mustafa A ^a   Freeman, Martin L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; NITRIC ACID DERIVATIVE;

BILE DUCT STONE; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; OBSTRUCTIVE JAUNDICE; PANCREATIC DUCT STENT; PANCREATITIS; PHARMACEUTICAL CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SPHINCTEROTOMY; VATER PAPILLA STENOSIS;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DRUG THERAPY, COMBINATION; HUMANS; INDOMETHACIN; NITRATES; PANCREATITIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84901989796     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.123     Document Type: Review

References (30)

1. Freeman ML. Complications of endoscopic retrograde cholangiopancreatography: Avoidance and management. Gastrointest Endosc Clin N Am 2012;22;567-86
2. Freeman ML. Prevention of post-ERCP pancreatitis: Pharmacologic solution or patient selection and pancreatic stents?. Gastroenterology 2003;124;1977-80
3. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335;909-18. (Pubitemid 26314443
4. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 2001;54;425-34. (Pubitemid 33661145
5. Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: A prospective multicenter study. Am J Gastroenterol 2009;104;31-40
6. Ito K, Fujita N, Noda Y, et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation?. A prospective randomized controlled trial. J Gastroenterol 2010;45;1183-91
7. CotéGA, Kumar N, Ansstas M, et al. Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc 2010;72;748-54
8. Tse F, Yuan Y, Moayyedi P, et al. Guide wire-Assisted cannulation for the prevention of post-ERCP pancreatitis: A systematic review and meta-Analysis. Endoscopy 2013;45;605-18
9. Lee TH, Park DH, Park JY, et al. Can wire-guided cannulation prevent post-ERCP pancreatitis?. A prospective randomized trial. Gastrointest Endosc 2009;69;444-9
10. Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: A meta-Analysis and systematic review. Gastrointest Endosc 2011;73;275-82
11. Mazaki T, Mado K, Masuda H, et al. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: An updated meta-Analysis. J Gastro enterol 2014;49;343-55
12. Freeman ML. Pancreatic stents for prevention of post-ERCP pancreatitis: For everyday practice or for experts only?. Gastrointest Endosc 2010;71;940-4
13. Das A, Singh P, Sivak MV Jr, et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: A cost-eff ectiveness analysis. Gastrointest Endosc 2007;65;960-8. (Pubitemid 46783815
14. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366;1414-22
15. Montano Loza A, Rodriguez Lomeli X, Garcia Correa JE, et al. Effect of the rectal administration of indomethacin on amylase serum levels aft er endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes. Revista Espanola de Enfermedades Digestivas 2007;99;330-6
16. Murray B, Carter R, Imrie C, et al. Diclofenac reduces the incidence of acute pancreatitis aft er endoscopic retrograde cholangiopancreatography. Gastroenterology 2003;124;1786-91. (Pubitemid 36666775
17. Khoshbaten M, Khorram H, Madad L, et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol 2008;23;e11-6
18. Otsuka T, Kawazoe S, Nakashita S, et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A randomized controlled trial. J Gastroenterol 2012;47;912-7
19. Katsinelos P, Fasoulas K, Paroutoglou G, et al. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: A randomized, double-blind, placebo-controlled trial. Endoscopy 2012;44;53-9
20. Sotoudehmanesh R, Khatibian M, Kolahdoozan S, et al. Indomethacin may reduce the incidence and severity of acute pancreatitis aft er ERCP. Am J Gastroenterol 2007;102;978-83. (Pubitemid 46698240
21. Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: Prophylaxis of post-ERCP pancreatitis. Endoscopy 2010;42;503-15
22. Sudhindran S, Bromwich E, Edwards PR. Prospective randomized doubleblind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001;88;1178-82. (Pubitemid 34015599
23. Moreto M, Zaballa M, Casado I, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial. Gastrointest Endosc 2003;57;1-7. (Pubitemid 36236791
24. Hao JY, Wu DF, Wang YZ, et al. Prophylactic Effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: A randomized placebo-controlled trial. World J Gastroenterol 2009;15;366-8
25. Kaff es AJ, Bourke MJ, Ding S, et al. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: Eff ects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 2006;64;351-7
26. Nojgaard C, Hornum M, Elkjaer M, et al. Does glyceryl nitrate prevent post-ERCP pancreatitis?. A prospective, randomized, double-blind, placebocontrolled multicenter trial. Gastrointest Endosc 2009;69;e31-7
27. Bhatia V, Ahuja V, Acharya SK, et al. Randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. J Clin Gastroenterol 2011;45;170-6
28. Sotoudehmanesh R, Eloubeidi MA, Asgari AA, et al. Randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis. Am J Gastroenterol 2014;109:903-9 (this issue
29. Akbar A, Abu Dayyeh BK, Baron TH, et al. Rectal nonsteroidal antiinfl ammatory drugs are superior to pancreatic duct stents in preventing pancreatitis aft er endoscopic retrograde cholangiopancreatography: A network meta-Analysis. Clin Gastroenterol Hepatol 2013;11;778-83
30. Kubiliun NM, Elmunzer BJ. Preventing pancreatitis aft er endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am 2013;23;769-86